South Africans are living longer
April 21, 2013, 11:49 a.m.
|
On 6 August 2001, President Thabo Mbeki wrote a letter to his Minister of Health, Manto Tshabalala-Msimang, questioning the priorities of South Africa's social spending. |
CANSA promotes untested supplement
March 22, 2013, midnight
|
Search the Internet for cancer organisations in South Africa and the top site returned will likely be the Cancer Association of South Africa (CANSA). |
Pet food advertising is better regulated than complementary medicines advertising
Feb. 8, 2013, 9:30 a.m.
|
In this article, which is quite technical but nevertheless an important read, Professor Roy Jobson of Rhodes University's Faculty of Pharmacy's Pharmacology Division explains that we should consider using the current advertising code for pet food as a guide to improving the code for complementary medicines. |
PEPFAR's anti-prostitution pledge is bad for health
Dec. 20, 2012, 8:54 a.m.
|
The US President's Emergency Plan for AIDS Relief (PEPFAR) should end its anti-prositution pledge. It harms sex workers and it's bad for health, especially HIV prevention and treatment. |
Three words doctors should use more often: "I don't know"
Dec. 10, 2012, 4:14 p.m.
|
In both clinical practice and guideline development, doctors need to get better at saying "I don't know". |
The stavudine debate
Nov. 27, 2012, 3:48 p.m.
|
At the opening of the SA HIV Clinicians Society there was an excellent debate on the stavudine (also known as d4T) 20mg trial. Francois Venter argued for and Eric Goemaere against. Dozens of Treatment Action Campaign members demonstrated against the trial and participated in the debate. |
Vitamin supplements: so many trials, so little use
Nov. 11, 2012, 6:19 p.m.
|
Do daily micronutrient (or multivitamin) supplements improve health? This has been a hotly debated question. In recent years several large studies have been published and received wide publicity. But the results have been inconsistent. |
Phase out D4T in poor countries
Nov. 6, 2012, 6:28 p.m.
|
In 2010 the World Health Organisation (WHO) changed the HIV treatment guidelines for poor countries and recommended switching from stavudine (D4T) to tenofovir disoproxil fumarate (TDF) for all patients on first line treatment. Stavudine (D4T) was previously one of three antiretroviral drugs (ARVs) recommended as first-line treatment but serious side effects, seen in many studies and treatment programmes, led to calls to use better, less toxic drugs. |
Patent law reform will benefit both people with cancer and HIV
Oct. 29, 2012, 8:58 a.m.
|
The Treatment Action Campaign (TAC) and Medicins Sans Frontieres (MSF) campaign to Fix the Patent Laws has been criticised by cancer groups in South Africa. |
Goldacre shows us how to be moral in the information age
Oct. 18, 2012, 5:02 p.m.
|
Dr Ben Goldacre used to write a popular quack-busting column called Bad Science for the British newspaper The Guardian. He became quite well-known for that column and his book by the same name. |
